Acute Aggression. Unspecified mood [affective] disorder
Conditions
Interventions
Intervention 1: Intervention Group 1: Injection of 5mg Haloperidol (Exir, Tehran, Iran). Intervention 2: Intervention Group 2: Injection of 50 mg Chlorpromazine (TehranChemie, Tehran, Iran). Intervent
Sponsors
Vice chancellor for research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age>18 Years Have consent to enter the study by patient accompaniment Have no Contraindication for Interventional Drug (For Instance Muscle Rigidity and Neuroleptic Malignant Syndrome) Having Verbal Violence in the Time of First Visit Having Physical Violence in the Time of First Visit
Exclusion criteria
Exclusion criteria: Patient Family's Refuse for Collaboration After the First Agreement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation Velocity. Timepoint: During the Intervention and 2 hours later after intervention. Method of measurement: Signs and Time of Aggression Registered list. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Effects of Sedative Drug. Timepoint: One Hour after Injection. Method of measurement: Drug side effects check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDelaram Eghtesadi, M.D
Isfahan University of Medical Sciences
Outcome results
None listed